Adenovirus News and Research

RSS

Adenoviruses most commonly cause respiratory illness; however, depending on the infecting serotype, they may also cause various other illnesses, such as gastroenteritis, conjunctivitis, cystitis, and rash illness. Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress.

Heterologous booster schedules are associated with increased protection against severe, omicron related COVID-19 outcomes

Study compared different coronavirus disease 2019 (COVID-19) vaccination regimens.

26 Jul 2023

Third dose COVID-19 booster vaccines offer lasting protection, trial shows

Third dose COVID-19 booster vaccines offer lasting protection after several months, according to the latest results of a nationwide trial.

25 Jul 2023

Advances in influenza research

This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in influenza research and how effective vaccines are developed.

From Sino Biological Inc. 30 Jun 2023

Researchers review the principles of universal vaccine development for key pandemic potential viruses

A recent review addressed the efforts to develop universal vaccines for viruses at family and genus levels.

16 Jun 2023

Trained immunity: its role in COVID-19 and potential in preparing for future infectious outbreaks

Researchers reported on the contribution of trained immune responses to protection against SARS-CoV-2 infections and future pandemics.

16 Jun 2023

Mutations that lead to intracranial aneurysms discovered

Researchers at the RIKEN Center for Brain Science (CBS) in Japan have discovered a set of related mutations that lead to intracranial aneurysms-;weakened blood vessels in the brain that can burst at any time.

14 Jun 2023

Study: Gentle cleansers just as effective as harsh soaps in killing viruses

Gentle cleansers are just as effective in killing viruses - including coronavirus - as harsh soaps, a new study by University of Sheffield experts has found.

11 Jun 2023

Study validates vaccine effectiveness: COVID-19 shots cut hospitalization and mortality rates in England

A new study examines hospitalization and mortality rates from COVID-19 before and after the rollout of the vaccine in England.

11 Jun 2023

Study may help advance data on oncolytic adenovirus mediated double suicide-gene therapy for high-grade brain tumors

Researchers in the Hermelin Brain Tumor Center at Henry Ford Health are leading a Phase I clinical trial studying the maximum tolerated dose of an oncolytic adenovirus, a mutated virus engineered to selectively replicate in and destroy cancer tissue, in combination with fractionated stereotactic radiosurgery among patients who are undergoing resection of a recurrent high-grade astrocytoma brain tumor.

8 Jun 2023

New variants of human metapneumovirus surge in Spain post-COVID, highlighting evolution and impact

Investigating Human metapneumovirus (HMPV) prevalence, genetic diversity, and evolution in respiratory tract infections (RTIs) for better understanding and management.

31 May 2023

Vector Biolabs expands viral vector manufacturing capacity and adds to QC capabilities

Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion to meet growing demand.

12 May 2023

Adenovirus and mRNA COVID vaccines differ in 6-month antibody durability

Research compares the durability of neutralizing antibody responses among recipients of three different COVID-19 vaccines (BNT162b2, mRNA-1273, and Ad26.COV2.S) over a period of 6 months.

11 May 2023

Researchers show the effect of SARS-CoV-2 infection on somatosensory abnormalities in a hamster model

In a recent article published in the journal Science Immunology, researchers in the United States performed a longitudinal cohort study in a golden hamster model to investigate the sensory-altering mechanisms induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared to an influenza A virus (IAV).

11 May 2023

Adenovirus News and Research

Further Reading

Heterologous booster schedules are associated with increased protection against severe, omicron related COVID-19 outcomes

Third dose COVID-19 booster vaccines offer lasting protection, trial shows

Advances in influenza research

Researchers review the principles of universal vaccine development for key pandemic potential viruses

Trained immunity: its role in COVID-19 and potential in preparing for future infectious outbreaks

Mutations that lead to intracranial aneurysms discovered

Study: Gentle cleansers just as effective as harsh soaps in killing viruses

Study validates vaccine effectiveness: COVID-19 shots cut hospitalization and mortality rates in England

Study may help advance data on oncolytic adenovirus mediated double suicide-gene therapy for high-grade brain tumors

New variants of human metapneumovirus surge in Spain post-COVID, highlighting evolution and impact

Vector Biolabs expands viral vector manufacturing capacity and adds to QC capabilities

Adenovirus and mRNA COVID vaccines differ in 6-month antibody durability

Researchers show the effect of SARS-CoV-2 infection on somatosensory abnormalities in a hamster model

SARS-CoV-2 infection leads to higher IgA levels in breast milk than vaccination

CRISPR-Cas9 system can help reduce adenovirus replication in human cells

New PET imaging breakthrough offers potential Alzheimer's diagnosis and treatment breakthrough

Pediatric invasive group A Streptococcal infections on the rise during respiratory virus outbreak

Nasal SARS-CoV-2 vaccine outperforms existing vaccines in preclinical trial

Complex assembly process involved in DNA virus replication revealed

Live attenuated nasal vaccine elicits superior immunity to SARS-CoV-2 variants in hamsters

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News